13G Filing: Healthcare Royalty Partners III, L.p. and Coherus Biosciences, Inc. (CHRS)

Page 11 of 14

Page 11 of 14 SEC Filing


CUSIP No. 19249H103


	(c)	Number of shares as to which the person has:

		(i) Sole power to vote or to direct the vote: 0 for all Reporting Persons

		(ii) Shared power to vote or to direct the vote:

		HealthCare Royalty Partners III, L.P.: 3,355,402
		HealthCare Royalty GP III, LLC: 3,355,402
		HealthCare Royalty Management, LLC: 3,355,402
		Todd C. Davis: 3,355,402
		Clarke B. Futch: 3,355,402
		Christopher A. White: 3,355,402
		Michael G. Carter: 3,355,402

		(iii) Sole power to dispose or to direct the disposition of: 0 for all Reporting Persons

		(iv) Shared power to dispose or to direct the disposition of:

		HealthCare Royalty Partners III, L.P.: 3,355,402
		HealthCare Royalty GP III, LLC: 3,355,402
		HealthCare Royalty Management, LLC: 3,355,402
		Todd C. Davis: 3,355,402
		Clarke B. Futch: 3,355,402
		Christopher A. White: 3,355,402
		Michael G. Carter: 3,355,402

Item 5.	Ownership of Five Percent or Less of a Class.

	If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ¨

Item 6.	Ownership of More than Five Percent on Behalf of Another Person.

	Not applicable.

Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.

	Not applicable.

Item 8.	Identification and Classification of Members of the Group.

	Not applicable.

Item 9.	Notice of Dissolution of Group.

	Not applicable.

Page 11 of 16

We may use your email to send marketing emails about our services. Click here to read our privacy policy.

Page 11 of 14